Scientists hunt for early warning signs in rare genetic lung disease
NCT ID NCT05297812
Summary
This study aims to find early signs that predict which people with Alpha-1 antitrypsin deficiency, a genetic disease that can damage the lungs and liver, will get worse quickly. Researchers are following 286 adults with the disease for three years, using CT scans and blood tests to track changes. The goal is to discover markers that can help identify high-risk patients earlier, so future treatments can be tested sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston University
Boston, Massachusetts, 02118, United States
-
Columbia University
New York, New York, 10032, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
National Jewish Health
Denver, Colorado, 80206, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of California - Los Angeles
Los Angeles, California, 90095, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
Conditions
Explore the condition pages connected to this study.